Mrs. Colleen King Goode

DNP, MA, FNP-BC, CNE | Nurse Practitioner

Mrs. Colleen King Goode is a Gambrills, Maryland based nurse practitioner. Her current practice location is 1404 S Main Chapel Way Ste 104, Gambrills. Patients can reach her at 443-814-9108. Mrs. Colleen King Goode is DNP, MA, FNP-BC, CNE and her NPI number (Unique professional ID assigned by NPPES) is 1508859984.
Mrs. Colleen King Goode has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.

Complete Profile:
Mrs. Colleen King Goode speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Mrs. Colleen King Goode
Specialization: Nurse Practitioner (NP)
Gender:Female
Credentials: DNP, MA, FNP-BC, CNE
Practice Address:1404 S Main Chapel Way Ste 104, Gambrills,
Maryland, 21054-1860
Phone:443-814-9108
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1508859984
NPI Enumeration Date: 31 Aug, 2005
NPI Last Update On: 14 Feb, 2023

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Mrs. Colleen King Goode
2947 Robin Rd,
York, Pennsylvania
Zip: 17404-5769
Patients can reach Mrs. Colleen King Goode at 1404 S Main Chapel Way Ste 104, Gambrills, Maryland or can call to book an appointment on 443-814-9108.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.